BPC-157 10mg

BPC-157 10 mg –

Overview:
BPC-157 (Body Protection Compound-157) is a synthetic peptide made of 15 amino acids, originally derived from a protective protein found in human gastric juice. It is commonly supplied in a 10 mg lyophilized (freeze-dried) vial and is widely used in laboratory and experimental research focused on tissue repair and regeneration.

Key Features:

• Active Compound: BPC-157 (pentadecapeptide)
• Dosage/Form: 10 mg per vial
• Formulation: Lyophilized powder (white/off-white)
• Purity: Typically ≥99% (HPLC-tested)
• Category: Research peptide (not an approved medicine)

Mechanism of Action (Research Context):

BPC-157 is studied for its ability to influence several biological pathways:

• Promotes angiogenesis (formation of new blood vessels)
• Enhances nitric oxide signaling and cellular repair pathways
• Supports fibroblast activity and tissue regeneration
• May protect and stabilize gut lining and internal tissues

Common Research Applications:

• Muscle, tendon, and ligament injury models
• Wound healing and tissue regeneration studies
• Gastrointestinal research (ulcers, inflammation)
• Cellular recovery and angiogenesis experiments

Physical & Handling Information:

• Appearance: White/off-white powder in sealed vial
• Reconstitution: Requires sterile/bacteriostatic water for lab use
• Storage:
  • Unmixed: −20 °C for long-term stability
  • After mixing: 2–8 °C (refrigerated)

Difference: 5 mg vs 10 mg

• Same compound, just double the total quantity
• 10 mg vial typically lasts longer and is often more cost-efficient per mg
• Concentration depends on how it is reconstituted, not vial size (lab context)

Safety & Warnings:

• Not approved for human or veterinary use
• Sold strictly for research purposes only
• Increasing global concern due to:
  • Lack of clinical human studies
  • Potential contamination in unregulated markets
  • Unknown long-term effects

Possible reported risks (non-clinical/anecdotal):

• Injection site reactions
• Fatigue, headaches
• Hormonal or metabolic disturbances

Legal Status:

BPC-157 is generally classified as a research chemical and is not approved as a pharmaceutical drug in most countries. Its sale and use are often restricted outside laboratory settings.

Important Note:

This information is for educational purposes only. BPC-157 remains an experimental compound, and any non-research use carries significant health and legal risks. Always consult a qualified healthcare professional before considering any substance.